BDBM580917 (3-((2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)oxy)azetidin-1- yl)(cyclopropyl)methanone::US11492348, Compound 129

SMILES Nc1ncc(cn1)-c1cc(OC2CN(C2)C(=O)C2CC2)cc(n1)N1CCOCC1

InChI Key InChIKey=ZUOOZRKTIWVPFW-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 580917   

LigandPNGBDBM580917(US11492348, Compound 129 | (3-((2-(2-aminopyrimidi...)
Affinity DataIC50: 34nMAssay Description:Quantification of ATP to ADP conversion as a measure of PI3Kα activity. Active PI3Kα (Life Technologies), in the presence or absence of PI3...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase [1-472,474-480](Human)
Neuropore Therapies

US Patent
LigandPNGBDBM580917(US11492348, Compound 129 | (3-((2-(2-aminopyrimidi...)
Affinity DataIC50: 3.46E+3nMAssay Description:Inhibition of the PI3K-AKT-mTOR pathway was measured by quantifying the loss of (Ser-473) pAKT using AlphaScreen (Perkin Elmer). B103 (Rat Neuroblast...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Neuropore Therapies

US Patent
LigandPNGBDBM580917(US11492348, Compound 129 | (3-((2-(2-aminopyrimidi...)
Affinity DataIC50: 2.95E+3nMAssay Description:The substrate was prepared in base reaction buffer (20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent